AMT

Honda Aircraft Company Again Awarded FAA Diamond-Level AMT Employer Award of Excellence

Retrieved on: 
Wednesday, March 8, 2023

GREENSBORO, N.C., March 8, 2023 /PRNewswire/ -- Honda Aircraft Company announced that it has once again received the AMT Employer Diamond Award for 2022, the highest level in the William (Bill) O'Brien Aviation Maintenance Technician (AMT) Awards program developed by the Federal Aviation Administration (FAA). This prestigious award recognizes the exceptional knowledge and skills of the Honda Aircraft Company's maintenance team, as well as the company's commitment to promoting and fostering effective technical training programs that exceed FAA regulatory requirements.

Key Points: 
  • "I am proud of our customer service team for their hard work and dedication in achieving this honor again," said Honda Aircraft Company President and CEO Hideto Yamasaki.
  • Honda Aircraft will continue to create a culture of excellence and provide employees with the training and resources they need to thrive in their field."
  • Honda Aircraft Company Head of Commercial Business Unit and VP of Customer Service Amod Kelkar said, "We are thrilled to win the AMT Employer Diamond Award again.
  • Honda Aircraft Company has once again demonstrated its commitment to excellence in all aspects of its operations by receiving the FAA AMT Employer Diamond Award.

Applied Molecular Transport Presents Additional Data from Oral AMT-101 Phase 2 FILLMORE Trial in Chronic Pouchitis at ECCO ’23 Congress

Retrieved on: 
Friday, March 3, 2023

SOUTH SAN FRANCISCO, Calif., March 03, 2023 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT) today announced additional Phase 2 data for oral AMT-101 in chronic pouchitis patients. AMT-101 is an investigational, once-daily, GI-selective, oral fusion of IL-10 and AMT’s proprietary carrier molecule, which is also in development for the treatment of rheumatoid arthritis (RA). AMT presented the data in Poster P584 Efficacy, Safety, and Tolerability of AMT-101: A Gut Selective Oral IL-10 Fusion in the Phase 2 FILLMORE Trial of Patients with Chronic Pouchitis at the European Crohn’s and Colitis Organisation (ECCO) ’23 Congress.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., March 03, 2023 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT) today announced additional Phase 2 data for oral AMT-101 in chronic pouchitis patients.
  • AMT presented the data in Poster P584 Efficacy, Safety, and Tolerability of AMT-101: A Gut Selective Oral IL-10 Fusion in the Phase 2 FILLMORE Trial of Patients with Chronic Pouchitis at the European Crohn’s and Colitis Organisation (ECCO) ’23 Congress.
  • “We are pleased to share these important new findings from the FILLMORE Phase 2 trial in patients with chronic pouchitis.
  • “These data further support advancement of once daily, oral AMT-101 for chronic pouchitis,” added Tahir Mahmood, Ph.D., chief executive officer and co-founder of AMT.

RestorixHealth, AMT Unite Under New Corporate Branding

Retrieved on: 
Tuesday, February 28, 2023

RestorixHealth, the nation’s leading wound care solutions company, is pleased to announce that American Medical Technologies (AMT) and RestorixHealth have completed an extensive rebrand and will unite under the RestorixHealth name.

Key Points: 
  • RestorixHealth, the nation’s leading wound care solutions company, is pleased to announce that American Medical Technologies (AMT) and RestorixHealth have completed an extensive rebrand and will unite under the RestorixHealth name.
  • View the full release here: https://www.businesswire.com/news/home/20230228005181/en/
    Committed to excellence in wound care, RestorixHealth is the wound care solutions company providing programs, services, products and education across the care continuum.
  • The brand name, RestorixHealth, is rooted in the company’s commitment to restoring health and best reflected the company’s values and commitment to excellence in wound care.
  • In addition, the RestorixHealth At-Home Wound Healing Services and At-Home Wound Care Supplies service lines will join AMT under the RestorixHealth name.

Precision OT Launches Distributor Alliance Program to Expand Distribution Capabilities Worldwide

Retrieved on: 
Tuesday, February 28, 2023

ROCHESTER, N.Y., Feb. 28, 2023 /PRNewswire/ -- Precision Optical Transceivers (Precision OT) , a leading provider of optical transceivers and related active/passive optical components, has officially announced its Distributor Alliance program, which was created in an effort to further expand its global distribution efforts.

Key Points: 
  • ROCHESTER, N.Y., Feb. 28, 2023 /PRNewswire/ -- Precision Optical Transceivers (Precision OT) , a leading provider of optical transceivers and related active/passive optical components, has officially announced its Distributor Alliance program, which was created in an effort to further expand its global distribution efforts.
  • Precision OT has entered into partnership with Advanced Media Technologies, Inc. (AMT), Navigator Nordic and Wood Communications ; each will sell Precision OT's full line of products.
  • Precision OT's newly announced distribution program is a continued manifestation of the company's remarkable growth, following expansion into a new state-of-the-art facility in early 2022.
  • "Our distribution partners have been carefully vetted and will provide further extension of the product quality, technical support and responsiveness Precision OT is known for worldwide."

Women in Manufacturing Education Foundation Board of Directors Announced

Retrieved on: 
Thursday, February 23, 2023

The Women in Manufacturing Education Foundation (WiMEF) is pleased to announce the election of 21 members to its 2023 Board of Directors, whose terms begin on April 1, 2023.

Key Points: 
  • The Women in Manufacturing Education Foundation (WiMEF) is pleased to announce the election of 21 members to its 2023 Board of Directors, whose terms begin on April 1, 2023.
  • These programs have helped thousands of women and men in the industry grow professionally and personally since the foundation’s inception.
  • The WiM Education Foundation (WiMEF) is the 501(c)(3) arm of Women in Manufacturing® Association, a more than 16,000-member-strong association dedicated to supporting, promoting and inspiring women who have chosen a career in manufacturing.
  • WiMEF provides and supports effective and affordable educational opportunities for women in manufacturing.

Kontron Presents Compact Motherboards With 13th Generation Intel® Core™ i Processors

Retrieved on: 
Tuesday, February 21, 2023

Kontron , a leading global provider of IoT/Embedded Computer Technology (ECT), announces that all ATX, µATX and mITX motherboards supporting the 12th generation Intel® Core™ i processor series will soon receive a comprehensive BIOS update to 13th generation.

Key Points: 

HOUSTEX 2023 Speakers Provide Real-World Solutions to Manufacturing Technology Adoption and Business Practices

Retrieved on: 
Tuesday, February 7, 2023

The two nonprofits have partnered on HOUSTEX 2023 to engage industry, academia and government agencies in bringing solutions to SMMs that drive the advancement of smart manufacturing principles.

Key Points: 
  • The two nonprofits have partnered on HOUSTEX 2023 to engage industry, academia and government agencies in bringing solutions to SMMs that drive the advancement of smart manufacturing principles.
  • HOUSTEX, which is part of the Manufacturing Technology Series — is one of four regional events conducted biannually to share knowledge, experience, technology and connections among manufacturers.
  • Panel Discussions Focus on Technology Adoption, Data Strategies
    Thought leadership will be in abundance at HOUSTEX 2023 with four panel discussions planned over the event’s three days.
  • The student summit will provide several keynote speakers and include guided show-floor tours of exhibiting manufacturing companies.

HOUSTEX 2023 Event Delivers Smart Manufacturing, Workforce Development Knowledge, Business Acumen to Southwest Manufacturers

Retrieved on: 
Wednesday, January 25, 2023

The two non-profits have partnered for HOUSTEX 2023 to engage industry, academia, and government agencies in bringing solutions to SMMs that drive the advancement of smart manufacturing principles.

Key Points: 
  • The two non-profits have partnered for HOUSTEX 2023 to engage industry, academia, and government agencies in bringing solutions to SMMs that drive the advancement of smart manufacturing principles.
  • HOUSTEX is part of the Manufacturing Technology (MT) Series – four regional events conducted bi-annually to share knowledge, experience, technology, and connections among manufacturers.
  • “At HOUSTEX, you will see first-hand how companies already are making ‘Smart’ changes, training their workforce, and getting great ROI.
  • Follow HOUSTEX 2023 by visiting the HOUSTEX 2023 website.

NCTC ANNOUNCES STRENGTHENED STRATEGIC PARTNERSHIP WITH AMT

Retrieved on: 
Tuesday, February 7, 2023

LENEXA, Kan. and DEERFIELD BEACH, Fla., Feb. 7, 2023 /PRNewswire/ -- The National Content & Technology Cooperative (NCTC) announced today its new agreement with Advanced Media Technologies (AMT), which will provide NCTC members access to AMT's portfolio of solutions, including hardware partners such as DZS, CommScope and Plume.

Key Points: 
  • Our continued partnership will benefit the NCTC membership with our extensive product knowledge and product availability.
  • "For over a decade, AMT has been a partner to NCTC and our members; we are now entering into a more strategic phase of our relationship, which is poised to bring our members even greater technology options, service offerings and cost savings," said Lou Borrelli, CEO NCTC.
  • The Premier Partner Agreement solidifies our relationship and will help AMT to better serve the NCTC membership.
  • Both the NCTC and AMT have identified manufacturers that we consider strategic and will be of the greatest benefit to the NCTC membership," said AMT CEO Tom McLaughlin.

Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe Ulcerative Colitis

Retrieved on: 
Thursday, December 22, 2022

“We thank our patients and sites for participating in the LOMBARD trial.

Key Points: 
  • “We thank our patients and sites for participating in the LOMBARD trial.
  • In the LOMBARD trial, patients received once-daily oral AMT-101 3mg or placebo in a 2:1 ratio.
  • The objectives of the LOMBARD trial were to assess the safety and efficacy of AMT-101 in patients with moderate-to-severe UC.
  • Of the 105 patients, 17.1% (12/70) of patients treated in the monotherapy arm (AMT-101 3mg) achieved clinical remission versus 20.0% (7/35) in patients receiving placebo at week 12.